Literature DB >> 2145174

Structural comparison of alpha/beta and gamma/delta T cell receptor-CD3 complexes reveals identical subunit interactions but distinct cross-linking patterns of T cell receptor chains.

J Van Neerven1, J E Coligan, F Koning.   

Abstract

Here we compare the subunit interactions within the alpha/beta and gamma/delta T cell receptor-CD3 (TcR-CD3) complexes. By using different detergent solubilization protocols, subunit interactions can be defined within such cell surface receptor complexes. It was found that in both TcR-CD3 complexes analogous subunit interactions can be defined: CD3 gamma and CD3 delta each form a stable complex with separate CD3 epsilon chains. Both the TcR gamma/delta and TcR alpha/beta form stable receptor complexes with these CD3 gamma/epsilon and CD3 delta/epsilon subunit. A zeta homodimer is present in these TcR-CD3 complexes. However, biochemical cross-linking results in a covalent bond between the CD3 gamma chain and the TcR beta chain in alpha/beta TcR-CD3 complexes and between the CD3 gamma chain and the TcR delta in gamma/delta TcR-CD3 complexes. This latter observation was independent of the type of TcR gamma/delta studied (e.g. disulfide or non-disulfide linked). These cross-linking results either indicate that the TcR beta and delta chains are each others structural homolog or that in TcR-CD3 complexes both TcR chains (alpha and beta, gamma and delta) are spatially closely associated with the CD3 gamma chain. The identical subunit interactions in the alpha/beta and gamma/delta TcR-CD3 complexes indicate no large structural differences between these receptor complexes but rather suggest a striking conservation of crucial interaction between subunits in the TcR-CD3 complexes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145174     DOI: 10.1002/eji.1830200932

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  CD3 delta deficiency arrests development of the alpha beta but not the gamma delta T cell lineage.

Authors:  V P Dave; Z Cao; C Browne; B Alarcon; G Fernandez-Miguel; J Lafaille; A de la Hera; S Tonegawa; D J Kappes
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Stoichiometry of the murine gammadelta T cell receptor.

Authors:  Sandra M Hayes; Paul E Love
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

3.  Modulation of WC1, a lineage-specific cell surface molecule of gamma/delta T cells augments cellular proliferation.

Authors:  M D Hanby-Flarida; O J Trask; T J Yang; C L Baldwin
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  Monoclonal antibodies that identify the CD3 molecules expressed specifically at the surface of porcine gammadelta-T cells.

Authors:  Huaizhi Yang; R Michael E Parkhouse; Thomas Wileman
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

5.  Signaling efficiency of the T cell receptor controlled by a single amino acid in the beta chain constant region.

Authors:  B T Bäckström; B T Hausmann; E Palmer
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

6.  One of the CD3epsilon subunits within a T cell receptor complex lies in close proximity to the Cbeta FG loop.

Authors:  Y Ghendler; A Smolyar; H C Chang; E L Reinherz
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

7.  Role of CD3 gamma in T cell receptor assembly.

Authors:  J Dietrich; A Neisig; X Hou; A M Wegener; M Gajhede; C Geisler
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

8.  Different composition of the human and the mouse gammadelta T cell receptor explains different phenotypes of CD3gamma and CD3delta immunodeficiencies.

Authors:  Gabrielle M Siegers; Mahima Swamy; Edgar Fernández-Malavé; Susana Minguet; Sylvia Rathmann; Alberto C Guardo; Verónica Pérez-Flores; Jose R Regueiro; Balbino Alarcón; Paul Fisch; Wolfgang W A Schamel
Journal:  J Exp Med       Date:  2007-10-08       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.